Business
ASX rises 0.9pc, buoyed by Victoria easing, vaccine development – The Australian Financial Review
The Australian sharemarket closed at a seven-month high on Monday as Victoria eased lockdown restrictions and on news of progress towards a COVID-19 vaccine.
“The crisis support has been significant and the tapering of such will present a drag. That said, the fiscal pivot is meaningful in size and focus. This combined with liquid and willing, monetary support allows for some calibration of an earnings recovery and more normalcy in the cycle.”
CSL led the market gains and a broadly firmer health sector with the British National Health Service deputy chief medical officer Jonathan Van-Tam suggesting the Oxford University vaccine being manufactured by …
-
Noosa News24 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
General15 hours agoDefence minister won’t say if security agencies or Trump administration pushed for Darwin Port backflip
-
General11 hours agoPoliticians asked how to Trump-proof Australia’s fragile economy on Q+A
-
General14 hours agoAsian, European stocks nosedive on tariff turmoil